A Study of the Cerebral Effect of Pegylated Interferon in Hepatitis C Positive Subjects
Phase of Trial: Phase IV
Latest Information Update: 18 Jul 2018
At a glance
- Drugs Peginterferon alfa-2b (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics
- 20 Jun 2018 Status changed from recruiting to completed.
- 21 Jul 2006 New trial record.